Table 2

 Basic characteristics of patients with COPD and controls*

VariableCOPD (n = 47)M = 28/F = 19Controls (n = 48)M = 29/F = 19T test for independent samples (p value)
NA, not available; NS, not significant; BMI, body mass index; FEV1, forced expiratory volume in 1 s; TLC, total lung capacity; RV, residual volume; Tlco, carbon monoxide transfer factor; MRC, Medical Research Council; 6MWD, 6-minute walk distance; SGRQ, St George’s Respiratory Disease Questionnaire; BODE, body mass index (B), obstruction (O), dyspnoea (D) and exercise endurance (E).
Data presented as mean (SD).
*Log transformation was performed on variables with non-normal distribution.
Age64 (8)64 (7)NS
BMI (kg/m2)26.6 (5.2)27.6 (4.8)NS
Smoking history (pack-years)70 (40)23 (3)<0.001
Pre-bronchodilator FEV1 (l)0.87 (0.33)2.46 (0.61)<0.001
Pre-bronchodilator FEV1 (% predicted)32 (10)90 (15)<0.001
Post-bronchodilator FEV1 (l)0.94 (0.36)NA
Post-bronchodilator FEV1 (% predicted)35 (11)NA
TLC (l)7.00 (1.57)5.33 (1.48)<0.001
TLC (% predicted)126 (2)95 (19)<0.001
RV (l)4.46 (1.36)2.07 (0.81)<0.001
RV (% predicted)211 (60)96 (33)<0.001
Tlco (ml/min/mmHg)9.9 (3.8)19.5 (6)<0.001
Tlco (% predicted)48 (5)92 (24)<0.001
MRC dyspnoea2.5 (0.8)0.08 (0.3)*<0.001
6MWD (m)365 (109)540 (95)<0.001
SGRQ composite score53 (18)4.8 (2.6)*<0.001
BODE index4.7 (1.8)2.2 (1.8)<0.001